DUMAC Inc’s Achieve Life Sciences ACHV Stock Holding History

DUMAC Inc’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-50,000	Closed	-$176K	–	10
2024 Q4	$176K	Buy	+50,000	New	+$227K	0.27%	10

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

DUMAC Inc's ACHV Position: Q1 2025 in Review

DUMAC Inc sold out of Achieve Life Sciences (ACHV) in Q1 2025, closing a stake of 50,000 shares — an estimated $176K sold.

DUMAC Inc first reported a position in ACHV in Q4 2024 and held it in 1 quarter. The position peaked at $176K in Q4 2024. 72 funds tracked by Wall St. Rank hold ACHV as of Q1 2025.

DUMAC Inc reported no remaining Achieve Life Sciences position as of Q1 2025 after selling out during the quarter.
DUMAC Inc sold 50,000 Achieve Life Sciences shares in Q1 2025, an estimated $176K.
DUMAC Inc first reported a position in Achieve Life Sciences in Q4 2024 and held it in 1 quarter.
DUMAC Inc's Achieve Life Sciences position peaked at $176K in Q4 2024.
72 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2025.

Based on DUMAC Inc's 13F filing for Q1 2025, filed 15 May 2025.